Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis

go back to reference Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compan MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Ostor A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3–15. https://doi.org/10.1136/annrheumdis-2015-207524 CrossRefPubMed Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compan MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Ostor A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3–15. https://​doi.​org/​10.​1136/​annrheumdis-2015-207524 CrossRefPubMed

go back to reference Coates LC, Helliwell PS (2016) Treating to target in psoriatic arthritis: how to implement in clinical practice. Ann Rheum Dis 75(4):640–643. https://doi.org/10.1136/annrheumdis-2015-208617 CrossRefPubMed Coates LC, Helliwell PS (2016) Treating to target in psoriatic arthritis: how to implement in clinical practice. Ann Rheum Dis 75(4):640–643. https://​doi.​org/​10.​1136/​annrheumdis-2015-208617 CrossRefPubMed

go back to reference Margiotta D, Navarini L, Vadacca M, Basta F, Lo Vullo M, Pignataro F, Zardi EM, Afeltra A (2016) Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. Eur Rev Med Pharmacol Sci 20(4):636–641PubMed Margiotta D, Navarini L, Vadacca M, Basta F, Lo Vullo M, Pignataro F, Zardi EM, Afeltra A (2016) Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. Eur Rev Med Pharmacol Sci 20(4):636–641PubMed

go back to reference Paley MA, Strand V, Kim AH (2017) From mechanism to therapies in systemic lupus erythematosus. Curr Opin Rheumatol 29(2):178–186. https://doi.org/10.1097/bor.0000000000000369 CrossRefPubMed Paley MA, Strand V, Kim AH (2017) From mechanism to therapies in systemic lupus erythematosus. Curr Opin Rheumatol 29(2):178–186. https://​doi.​org/​10.​1097/​bor.​0000000000000369​ CrossRefPubMed

go back to reference Afeltra A, Gigante A, Margiotta DPE, Taffon C, Cianci R, Barbano B, Liberatori M, Amoroso A, Fanelli FR (2015) The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study. Intern Emerg Med 10(6):677–683. https://doi.org/10.1007/s11739-015-1212-x CrossRefPubMed Afeltra A, Gigante A, Margiotta DPE, Taffon C, Cianci R, Barbano B, Liberatori M, Amoroso A, Fanelli FR (2015) The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study. Intern Emerg Med 10(6):677–683. https://​doi.​org/​10.​1007/​s11739-015-1212-x CrossRefPubMed

go back to reference Margiotta DPE, Basta F, Batani V, Afeltra A (2018) Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review. BMC Nephrol 19(1):54. https://doi.org/10.1186/s12882-018-0847-z CrossRefPubMedPubMedCentral Margiotta DPE, Basta F, Batani V, Afeltra A (2018) Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review. BMC Nephrol 19(1):54. https://​doi.​org/​10.​1186/​s12882-018-0847-z CrossRefPubMedPubMedCentral

go back to reference Vadacca M, Margiotta D, Sambataro D, Buzzulini F, Lo Vullo M, Rigon A, Afeltra A (2010) [BAFF/APRIL pathway in Sjogren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity]. (Pathway BAFF/APRIL nella sindrome di Sjogren e nel lupus eritematoso sistemico: relazione con infiammazione cronica e attivita di malattia.). Reumatismo 62(4):259–265PubMed Vadacca M, Margiotta D, Sambataro D, Buzzulini F, Lo Vullo M, Rigon A, Afeltra A (2010) [BAFF/APRIL pathway in Sjogren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity]. (Pathway BAFF/APRIL nella sindrome di Sjogren e nel lupus eritematoso sistemico: relazione con infiammazione cronica e attivita di malattia.). Reumatismo 62(4):259–265PubMed

go back to reference Fasano S, Margiotta DP, Navarini L, Pierro L, Pantano I, Riccardi A, Afeltra A, Valentini G (2017) Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review. Lupus 26(14):1463–1472. https://doi.org/10.1177/0961203317722847 CrossRefPubMed Fasano S, Margiotta DP, Navarini L, Pierro L, Pantano I, Riccardi A, Afeltra A, Valentini G (2017) Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review. Lupus 26(14):1463–1472. https://​doi.​org/​10.​1177/​0961203317722847​ CrossRefPubMed

go back to reference van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrom K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirjak L, Derksen R, Dorner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M (2014) Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73(6):958–967. https://doi.org/10.1136/annrheumdis-2013-205139 CrossRefPubMed van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrom K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirjak L, Derksen R, Dorner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M (2014) Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73(6):958–967. https://​doi.​org/​10.​1136/​annrheumdis-2013-205139 CrossRefPubMed

go back to reference Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers J-O, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG (2017) International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev 16(9):911–924. https://doi.org/10.1016/j.autrev.2017.07.012 CrossRefPubMed Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers J-O, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG (2017) International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev 16(9):911–924. https://​doi.​org/​10.​1016/​j.​autrev.​2017.​07.​012 CrossRefPubMed

go back to reference Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61(1):108–110CrossRefPubMed Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61(1):108–110CrossRefPubMed

go back to reference Margiotta DPE, Basta F, Dolcini G, Batani V, Navarini L, Afeltra A (2017) The relation between, metabolic syndrome and quality of life in patients with systemic lupus erythematosus. PLoS One 12(11):e0187645. https://doi.org/10.1371/journal.pone.0187645 CrossRefPubMedPubMedCentral Margiotta DPE, Basta F, Dolcini G, Batani V, Navarini L, Afeltra A (2017) The relation between, metabolic syndrome and quality of life in patients with systemic lupus erythematosus. PLoS One 12(11):e0187645. https://​doi.​org/​10.​1371/​journal.​pone.​0187645 CrossRefPubMedPubMedCentral

go back to reference Margiotta DPE, Basta F, Dolcini G, Batani V, Lo Vullo M, Vernuccio A, Navarini L, Afeltra A (2018) Physical activity and sedentary behavior in patients with systemic lupus erythematosus. PLoS One 13(3):e0193728. https://doi.org/10.1371/journal.pone.0193728 CrossRefPubMedPubMedCentral Margiotta DPE, Basta F, Dolcini G, Batani V, Lo Vullo M, Vernuccio A, Navarini L, Afeltra A (2018) Physical activity and sedentary behavior in patients with systemic lupus erythematosus. PLoS One 13(3):e0193728. https://​doi.​org/​10.​1371/​journal.​pone.​0193728 CrossRefPubMedPubMedCentral

go back to reference Moraleda V, Prados G, Martinez MP, Sanchez AI, Sabio JM, Miro E (2017) Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus. Int J Rheum Dis 20(10):1541–1550. https://doi.org/10.1111/1756-185x.13081 CrossRefPubMed Moraleda V, Prados G, Martinez MP, Sanchez AI, Sabio JM, Miro E (2017) Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus. Int J Rheum Dis 20(10):1541–1550. https://​doi.​org/​10.​1111/​1756-185x.​13081 CrossRefPubMed

go back to reference Mirbagher L, Gholamrezaei A, Hosseini N, Sayed Bonakdar Z (2016) Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life. Int J Rheum Dis 19(3):305–311. https://doi.org/10.1111/1756-185x.12418 CrossRefPubMed Mirbagher L, Gholamrezaei A, Hosseini N, Sayed Bonakdar Z (2016) Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life. Int J Rheum Dis 19(3):305–311. https://​doi.​org/​10.​1111/​1756-185x.​12418 CrossRefPubMed

go back to reference Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, Makimoto K (2017) Predictors of poor sleep quality in patients with systemic lupus erythematosus. Clin Rheumatol 36(5):1053–1062. https://doi.org/10.1007/s10067-017-3545-5 CrossRefPubMed Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, Makimoto K (2017) Predictors of poor sleep quality in patients with systemic lupus erythematosus. Clin Rheumatol 36(5):1053–1062. https://​doi.​org/​10.​1007/​s10067-017-3545-5 CrossRefPubMed

go back to reference Palagini L, Tani C, Mauri M, Carli L, Vagnani S, Bombardieri S, Gemignani A, Mosca M (2014) Sleep disorders and systemic lupus erythematosus. Lupus 23(2):115–123. https://doi.org/10.1177/0961203313518623 CrossRefPubMed Palagini L, Tani C, Mauri M, Carli L, Vagnani S, Bombardieri S, Gemignani A, Mosca M (2014) Sleep disorders and systemic lupus erythematosus. Lupus 23(2):115–123. https://​doi.​org/​10.​1177/​0961203313518623​ CrossRefPubMed

go back to reference Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, Banaszkiewicz D, Smolenska Z, Czuszynska Z, Siebert J (2018) Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus 27(3):454–460. https://doi.org/10.1177/0961203317751858 CrossRefPubMed Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, Banaszkiewicz D, Smolenska Z, Czuszynska Z, Siebert J (2018) Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus 27(3):454–460. https://​doi.​org/​10.​1177/​0961203317751858​ CrossRefPubMed

go back to reference Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, Hobfoll SE, Block JA, Jolly M (2018) Sleep disturbance and depression symptoms mediate the relationship between pain and cognitive dysfunction in lupus patients. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.23593 Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, Hobfoll SE, Block JA, Jolly M (2018) Sleep disturbance and depression symptoms mediate the relationship between pain and cognitive dysfunction in lupus patients. Arthritis Care Res (Hoboken). https://​doi.​org/​10.​1002/​acr.​23593

go back to reference Greenwood KM, Lederman L, Lindner HD (2008) Self-reported sleep in systemic lupus erythematosus. Clin Rheumatol 27(9):1147–1151. https://doi.org/10.1007/s10067-008-0884-2 CrossRefPubMed Greenwood KM, Lederman L, Lindner HD (2008) Self-reported sleep in systemic lupus erythematosus. Clin Rheumatol 27(9):1147–1151. https://​doi.​org/​10.​1007/​s10067-008-0884-2 CrossRefPubMed

go back to reference Zhao Q, Deng N, Chen S, Cui Y, Du X, Gu Z (2018) Systemic lupus erythematosus is associated with negatively variable impacts on domains of sleep disturbances: a systematic review and meta-analysis. Psychol Health Med 23:685–697. https://doi.org/10.1080/13548506.2018.1442011 CrossRefPubMed Zhao Q, Deng N, Chen S, Cui Y, Du X, Gu Z (2018) Systemic lupus erythematosus is associated with negatively variable impacts on domains of sleep disturbances: a systematic review and meta-analysis. Psychol Health Med 23:685–697. https://​doi.​org/​10.​1080/​13548506.​2018.​1442011 CrossRefPubMed

go back to reference Da Costa D, Bernatsky S, Dritsa M, Clarke AE, Dasgupta K, Keshani A, Pineau C (2005) Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 53(2):272–278. https://doi.org/10.1002/art.21069 CrossRefPubMed Da Costa D, Bernatsky S, Dritsa M, Clarke AE, Dasgupta K, Keshani A, Pineau C (2005) Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 53(2):272–278. https://​doi.​org/​10.​1002/​art.​21069 CrossRefPubMed

go back to reference Palagini L, Tani C, Bruno RM, Gemignani A, Mauri M, Bombardieri S, Riemann D, Mosca M (2014) Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms? Lupus 23(13):1350–1357. https://doi.org/10.1177/0961203314540762 CrossRefPubMed Palagini L, Tani C, Bruno RM, Gemignani A, Mauri M, Bombardieri S, Riemann D, Mosca M (2014) Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms? Lupus 23(13):1350–1357. https://​doi.​org/​10.​1177/​0961203314540762​ CrossRefPubMed

go back to reference Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G (2009) The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 19(4):407–415. https://doi.org/10.1007/s10165-009-0185-x CrossRefPubMed Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G (2009) The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 19(4):407–415. https://​doi.​org/​10.​1007/​s10165-009-0185-x CrossRefPubMed

go back to reference Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686. https://doi.org/10.1002/art.34473 CrossRefPubMedPubMedCentral Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686. https://​doi.​org/​10.​1002/​art.​34473 CrossRefPubMedPubMedCentral

go back to reference Curcio G, Tempesta D, Scarlata S, Marzano C, Moroni F, Rossini PM, Ferrara M, De Gennaro L (2013) Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI). Neurol Sci 34(4):511–519. https://doi.org/10.1007/s10072-012-1085-y CrossRefPubMed Curcio G, Tempesta D, Scarlata S, Marzano C, Moroni F, Rossini PM, Ferrara M, De Gennaro L (2013) Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI). Neurol Sci 34(4):511–519. https://​doi.​org/​10.​1007/​s10072-012-1085-y CrossRefPubMed

go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640CrossRefPubMed

go back to reference Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP, Trial O-S (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550–2558. https://doi.org/10.1056/NEJMoa051135 CrossRefPubMed Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP, Trial O-S (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550–2558. https://​doi.​org/​10.​1056/​NEJMoa051135 CrossRefPubMed

go back to reference Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcon GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142(12 Pt 1):953–962CrossRefPubMed Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcon GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142(12 Pt 1):953–962CrossRefPubMed

go back to reference Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefPubMed Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefPubMed

go back to reference Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G (2014) Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 53(8):1470–1476. https://doi.org/10.1093/rheumatology/keu148 CrossRef Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G (2014) Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 53(8):1470–1476. https://​doi.​org/​10.​1093/​rheumatology/​keu148 CrossRef

go back to reference Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome--a new worldwide definition. Lancet (London, England) 366(9491):1059–1062. https://doi.org/10.1016/S0140-6736(05)67402-8 CrossRef Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome--a new worldwide definition. Lancet (London, England) 366(9491):1059–1062. https://​doi.​org/​10.​1016/​S0140-6736(05)67402-8 CrossRef

go back to reference Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51(11):1025–1036CrossRefPubMed Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51(11):1025–1036CrossRefPubMed

go back to reference Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://doi.org/10.1186/1477-7525-1-79 CrossRefPubMedPubMedCentral Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://​doi.​org/​10.​1186/​1477-7525-1-79 CrossRefPubMedPubMedCentral

go back to reference Pancheri P, Picardi A, Pasquini M, Gaetano P, Biondi M (2002) Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. J Affect Disord 68(1):41–47CrossRefPubMed Pancheri P, Picardi A, Pasquini M, Gaetano P, Biondi M (2002) Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. J Affect Disord 68(1):41–47CrossRefPubMed

go back to reference Sacco R, Santangelo G, Stamenova S, Bisecco A, Bonavita S, Lavorgna L, Trojano L, D'Ambrosio A, Tedeschi G, Gallo A (2016) Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol 23(4):744–750. https://doi.org/10.1111/ene.12932 CrossRefPubMed Sacco R, Santangelo G, Stamenova S, Bisecco A, Bonavita S, Lavorgna L, Trojano L, D'Ambrosio A, Tedeschi G, Gallo A (2016) Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol 23(4):744–750. https://​doi.​org/​10.​1111/​ene.​12932 CrossRefPubMed

go back to reference Bressi C, Taylor G, Parker J, Bressi S, Brambilla V, Aguglia E, Allegranti I, Bongiorno A, Giberti F, Bucca M, Todarello O, Callegari C, Vender S, Gala C, Invernizzi G (1996) Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res 41(6):551–559CrossRefPubMed Bressi C, Taylor G, Parker J, Bressi S, Brambilla V, Aguglia E, Allegranti I, Bongiorno A, Giberti F, Bucca M, Todarello O, Callegari C, Vender S, Gala C, Invernizzi G (1996) Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res 41(6):551–559CrossRefPubMed

go back to reference Valencia-Flores M, Resendiz M, Castano VA, Santiago V, Campos RM, Sandino S, Valencia X, Alcocer J, Ramos GG, Bliwise DL (1999) Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum 42(10):2189–2193. https://doi.org/10.1002/1529-0131(199910)42:10<2189::aid-anr21>3.0.co;2-v CrossRefPubMed Valencia-Flores M, Resendiz M, Castano VA, Santiago V, Campos RM, Sandino S, Valencia X, Alcocer J, Ramos GG, Bliwise DL (1999) Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum 42(10):2189–2193. https://​doi.​org/​10.​1002/​1529-0131(199910)42:​10<2189:​:​aid-anr21>3.​0.​co;2-v CrossRefPubMed

go back to reference Kasitanon N, Achsavalertsak U, Maneeton B, Wangkaew S, Puntana S, Sukitawut W, Louthrenoo W (2013) Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus. Lupus 22(13):1353–1360. https://doi.org/10.1177/0961203313507355 CrossRefPubMed Kasitanon N, Achsavalertsak U, Maneeton B, Wangkaew S, Puntana S, Sukitawut W, Louthrenoo W (2013) Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus. Lupus 22(13):1353–1360. https://​doi.​org/​10.​1177/​0961203313507355​ CrossRefPubMed

go back to reference Buysse DJ, Hall ML, Strollo PJ, Kamarck TW, Owens J, Lee L, Reis SE, Matthews KA (2008) Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 4(6):563–571PubMedPubMedCentral Buysse DJ, Hall ML, Strollo PJ, Kamarck TW, Owens J, Lee L, Reis SE, Matthews KA (2008) Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 4(6):563–571PubMedPubMedCentral

go back to reference Baillet M, Cosin C, Schweitzer P, Peres K, Catheline G, Swendsen J, Mayo W (2016) Mood influences the concordance of subjective and objective measures of sleep duration in older adults. Front Aging Neurosci 8:181. https://doi.org/10.3389/fnagi.2016.00181 CrossRefPubMedPubMedCentral Baillet M, Cosin C, Schweitzer P, Peres K, Catheline G, Swendsen J, Mayo W (2016) Mood influences the concordance of subjective and objective measures of sleep duration in older adults. Front Aging Neurosci 8:181. https://​doi.​org/​10.​3389/​fnagi.​2016.​00181 CrossRefPubMedPubMedCentral

go back to reference McKinley PS, Ouellette SC, Winkel GH (1995) The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum 38(6):826–834CrossRefPubMed McKinley PS, Ouellette SC, Winkel GH (1995) The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum 38(6):826–834CrossRefPubMed

go back to reference Moon SJ, Kang KY, Kwok SK, Ju JH, Hong YS, Park SH, Jeon CH, Choi ST, Song JS, Min JK (2018) Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort. Int J Rheum Dis 21(6):1173–1184. https://doi.org/10.1111/1756-185X.13320 CrossRefPubMed Moon SJ, Kang KY, Kwok SK, Ju JH, Hong YS, Park SH, Jeon CH, Choi ST, Song JS, Min JK (2018) Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort. Int J Rheum Dis 21(6):1173–1184. https://​doi.​org/​10.​1111/​1756-185X.​13320 CrossRefPubMed

go back to reference Neubauer DN, Pandi-Perumal SR, Spence DW, Buttoo K, Monti JM (2018) Pharmacotherapy of insomnia. J Cent Nerv Syst Dis 10:1179573518770672. https://doi.org/10.1177/1179573518770672 CrossRefPubMedPubMedCentral Neubauer DN, Pandi-Perumal SR, Spence DW, Buttoo K, Monti JM (2018) Pharmacotherapy of insomnia. J Cent Nerv Syst Dis 10:1179573518770672. https://​doi.​org/​10.​1177/​1179573518770672​ CrossRefPubMedPubMedCentral

go back to reference Jansson-Frojmark M, Norell-Clarke A (2018) The cognitive treatment components and therapies of cognitive behavioral therapy for insomnia: a systematic review. Sleep Med Rev 42:19–36. https://doi.org/10.1016/j.smrv.2018.05.001 CrossRefPubMed Jansson-Frojmark M, Norell-Clarke A (2018) The cognitive treatment components and therapies of cognitive behavioral therapy for insomnia: a systematic review. Sleep Med Rev 42:19–36. https://​doi.​org/​10.​1016/​j.​smrv.​2018.​05.​001 CrossRefPubMed

go back to reference Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76(2):318–328. https://doi.org/10.1136/annrheumdis-2016-209724 CrossRefPubMed Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76(2):318–328. https://​doi.​org/​10.​1136/​annrheumdis-2016-209724 CrossRefPubMed